Integrating pharmacogenomics- metabolomics towards realising personalised medicine for colorectal cancer patients treated with 5-fluorouracil / Hazwanie Hashim
Colorectal cancer (CRC) is one of the most common cancers among men and women in Malaysia. 5-flurouracil (5-FU)/leucovorin is the standard chemotherapy for colorectal cancer and various other types of cancer including breast, head and neck cancers. However, standard method for dosing 5-fluorouracil...
Main Author: | Hashim, Hazwanie |
---|---|
Format: | Book Section |
Language: | English |
Published: |
Institute of Graduate Studies, UiTM
2012
|
Subjects: | |
Online Access: | http://ir.uitm.edu.my/id/eprint/19122/ http://ir.uitm.edu.my/id/eprint/19122/1/ABS_HAZWANIE%20HASHIM%20TDRA%20VOL%201%20IGS%2012.pdf |
Similar Items
-
Metabolomics and pharmacogenetics based 5-fluorouracil monitoring in colorectal cancer patients
by: Zakaria, Bannur, et al.
Published: (2014) -
Potential of dihydropyrimidine dehydrogenase genotypes in personalising 5-fluorouracil therapy among colorectal cancer patients
by: Ngow, Harris Abdullah, et al.
Published: (2011) -
Quality of life among colorectal cancer screening patients in Malaysia
by: Intan Melati Abu Bakar,, et al.
Published: (2019) -
Mitochondrial DNA quantity changes in leucocytes of cancer
patients on cisplatin and 5-fluorouracil regimen
by: Khaing, Ei Phyo, et al.
Published: (2016) -
Cancer pharmacogenomics: the relevance of genetic profile in optimization drug therapy for azathiopurine and 5-fluorouracil / Prof Madya Dr Teh Lay Kek and Prof Dr Mohd Zaki Salleh
by: Teh, Lay Kek, et al.
Published: (2010)